Facebook Instagram X-twitter Linkedin

KissPeptin-10 (10mg)

Table of Contents

  • Quickstart Highlights

Kisspeptin-10 (10mg) protocols focus on this synthetic peptide fragment of the kisspeptin protein, which plays a key role in regulating the hypothalamic–pituitary–gonadal (HPG) axis. Kisspeptin-10 is studied for its ability to stimulate natural GnRH (gonadotropin-releasing hormone) release, which may influence downstream LH and FSH secretion. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration
  • Typical dosing range: 100–500 mcg per dose (subcutaneous)
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Support natural reproductive hormone signaling via GnRH activation
  • Schedule: Intermittent or daily subcutaneous injections, depending on protocol design
  • Dose Range: 100–500 mcg per administration
  • Usage Style: Often used in short cycles rather than continuous long-term use
  • Dosing Protocol

Suggested approach for the 10 mg vial format.

  • Start: 100–200 mcg per dose to assess response
  • Target: 200–500 mcg per dose, depending on protocol goals
  • Frequency: 1–3 times per week or short daily cycles (subcutaneous)
  • Vial Duration: One 10 mg vial typically supports multiple weeks of intermittent use
  • Timing: Evening or pre-bed use is commonly preferred in research protocols
  • Mechanism of Action

Kisspeptin-10 is a decapeptide derived from the KISS1 gene product, acting as a powerful upstream regulator of the reproductive hormone axis. It binds to the GPR54 (KISS1R) receptor in the hypothalamus, stimulating the release of GnRH.

This GnRH release triggers the pituitary gland to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which are essential for reproductive endocrine function. Because of this upstream control role, kisspeptin is considered a key “gatekeeper” of puberty, fertility signaling, and gonadal hormone regulation in research settings.

  • Potential Benefits & Side Effects

Observations based on preclinical and early-stage research.

Potential Benefits:

  • May stimulate natural LH and FSH release
  • May support hormonal balance and reproductive signaling
  • Potential use in research on fertility regulation and endocrine function
  • May help assess HPG axis responsiveness in clinical studies

Possible Side Effects:

  • Mild flushing or warmth sensation
  • Headache or temporary lightheadedness
  • Possible injection-site irritation
  • Hormonal fluctuations depending on dose and sensitivity
  • Long-term human safety data are limited; it remains investigational